Elanco Animal Health
ELAN
478 hedge funds and large institutions have $16.2B invested in Elanco Animal Health in 2021 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 176 increasing their positions, 135 reducing their positions, and 48 closing their positions.
69% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 48
30% more repeat investments, than reductions
Existing positions increased: 176 | Existing positions reduced: 135
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
18% more capital invested
Capital invested by funds: $13.8B → $16.2B (+$2.48B)
7% more funds holding
Funds holding: 448 → 478 (+30)
0.11% more ownership
Funds ownership: 98.96% → 99.07% (+0.11%)
4% less call options, than puts
Call options by funds: $55.4M | Put options by funds: $57.8M
Top Buyers
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$295M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$127M |
| 3 |
BlackRock
New York
|
-$119M |
| 4 |
State Street
Boston,
Massachusetts
|
-$68.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$58.6M |
ELAN Hedge Fund Activity: Q2 2021 in Review
478 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2021, worth a combined $16.2B — up 18% from $13.8B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new ELAN positions and 48 closed out — a net gain of 33 holders — while 176 added to existing stakes and 135 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $165M. The largest seller was Janus Henderson Group, cutting an estimated $295M.
- 478 institutional investors held Elanco Animal Health (ELAN) as of Q2 2021, up from 448 in Q1 2021.
- Funds reported $16.2B of Elanco Animal Health stock for Q2 2021, up 18% quarter-over-quarter.
- 81 funds opened new Elanco Animal Health positions in Q2 2021 and 48 closed out, a net change of +33 holders.
- The largest Elanco Animal Health buyer in Q2 2021 was T. Rowe Price Associates, an estimated $165M added.
- The largest Elanco Animal Health seller in Q2 2021 was Janus Henderson Group, an estimated $295M sold.
Based on aggregated 13F filings for Q2 2021.